Details for Patent: 9,987,285
✉ Email this page to a colleague
Which drugs does patent 9,987,285 protect, and when does it expire?
Patent 9,987,285 protects RUBRACA and is included in one NDA.
This patent has twenty-three patent family members in thirteen countries.
Drugs Protected by US Patent 9,987,285
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaand | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-001 | Dec 19, 2016 | RX | Yes | No | 9,987,285 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Pharmaand | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-003 | May 1, 2017 | RX | Yes | No | 9,987,285 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Pharmaand | RUBRACA | rucaparib camsylate | TABLET;ORAL | 209115-002 | Dec 19, 2016 | RX | Yes | Yes | 9,987,285 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,987,285
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015305696 | ⤷ Start Trial | |||
| Australia | 2019272064 | ⤷ Start Trial | |||
| Brazil | 112017000865 | ⤷ Start Trial | |||
| Canada | 2955495 | ⤷ Start Trial | |||
| China | 106794185 | ⤷ Start Trial | |||
| China | 113209033 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
